A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 129
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : LRFS
Long Form : local relapse-free survival
No. Year Title Co-occurring Abbreviation
2020 Genomic Biomarkers of Survival in Patients with Adenocarcinoma of the Uterine Cervix Receiving Chemoradiotherapy. AC, CRT, DFS, DMFS, FIGO, IHC, MCL1, NGS, TMN, TNF-alpha
2020 Hypofractionation vs. conventional radiotherapy fractionation in the conservative treatment of T1 glottic cancer: a prospective cohort study. LFS, MFS, OS, RFS
2020 Induction Chemotherapy Improved Long Term Outcomes in Stage IV Locoregional Advanced Nasopharyngeal Carcinoma. CC, CCRT, CCRT, DMFS, FFS, IC, LANPC, OS, RRFS
2020 Lessons from radiochemotherapy and modern image-guided adaptive brachytherapy followed by hysterectomy. HT, IGABT, OS, PRFS, RCT
2020 Maximizing the Clinical Benefit of Radiotherapy in Solitary Plasmacytoma: An International Multicenter Analysis. CR, EMP, LC, MMFS, OS, PFS, RT, SBP, SP
2020 Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa. AJCC, CI, DMFS, HR, IMRT, NPC, OS
2020 Pre-treatment intravoxel incoherent motion diffusion-weighted imaging predicts treatment outcome in nasopharyngeal carcinoma. AUCs, DFS, DMFS, IVIM-DWI, NPC, RRFS
2020 The prognostic role of FDG PET/CT before combined radio-chemotherapy in anal cancer patients. CFS, DFS, DSS, MFS, OS, RCT, WB
2020 The Role of Prognostic Factors in Salivary Gland Tumors Treated by Surgery and Adjuvant Radio- or Chemoradiotherapy - A Single Institution Experience. CSS, OS, RFS
10  2019 Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients. CRT, DeltaGICA, DRFS, LAPC, OS, PFS
11  2019 Five-year oncological outcome after a single fraction of accelerated partial breast irradiation in the elderly. APBI, MIB, OS, pts, SS
12  2019 Prognostic value of estrogen receptor-alpha and progesterone receptor in curatively resected colorectal cancer: a retrospective analysis with independent validations. CRC, DMFS, ERalpha, HRs, OS, PR
13  2019 Prognostic Value of the Pretreatment Primary Lesion Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Nasopharyngeal Carcinoma. DCE-MRI, DMFS, LRRFS, NPC
14  2019 Surgery in reference centers improves survival of sarcoma patients: a nationwide study. EFS, MDTB, NETSARC, NF1, OS
15  2019 Surgery in reference centers improves survival of sarcoma patients: a nationwide study. EFS, MDTB, NETSARC, NF1, OS
16  2019 The development and external validation of simplified T category classification for nasopharyngeal carcinoma to improve the prognostic value in the intensity-modulated radiotherapy era. DFS, IMRT, NPC, OS, proT2
17  2019 The primary lesion apparent diffusion coefficient is a prognostic factor for locoregionally advanced nasopharyngeal carcinoma: a retrospective study. ADC, AUC, DFS, DMFS, LA-NPC, OS
18  2019 The Role of Post-Neoadjuvant Chemotherapy Tumor Volume for Prognostication and Treatment Guidance in Loco-Regionally Advanced Nasopharyngeal Carcinoma. CCRT, CT, DFS, DMFS, IMRT, LA-NPC, NACT, OS, RPA, TNV
19  2019 Tumor grade and molecular subtypes on local control in breast cancer radiotherapy: Does fractionation really matter? A retrospective control study group. HRT, SRT
20  2019 Watch and Wait Approach for Re-excision After Unplanned Yet Macroscopically Complete Excision of Extremity and Superficial Truncal Soft Tissue Sarcoma is Safe and Does Not Affect Metastatic Risk or Amputation Rate. HR, MRFS, OS, RE, STS, UE
21  2018 Breast-conserving therapy for primary Ductal Carcinoma in Situ in The Netherlands: A multi-center study and population-based analysis. BCT, DSS, WBI
22  2018 Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers. DFS, DMFS, HR, IMRT, NPC, OS, UICC/AJCC
23  2018 Efficacy and safety of primary surgery with postoperative radiotherapy in head and neck mucosal melanoma: a single-arm Phase II study. AC, DMFS, HNMM, OS, PNR, RRFS
24  2018 Efficacy and tolerance of high-dose-rate brachytherapy boost after external radiotherapy in the treatment of squamous cell carcinoma of the anal canal. ASCC, CFS, DFS, EBRT, HDR-BT, MFS, OS, OTT, pts
25  2018 FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients. BTV, DRFS, HTT, MPM, MTV, OS, TLG
26  2018 hERG1 channel expression associates with molecular subtypes and prognosis in breast cancer. BC, MFS
27  2018 Intensity-modulated radiotherapy combined with endostar has similar efficacy but weaker acute adverse reactions than IMRT combined with chemotherapy in the treatment of locally advanced nasopharyngeal carcinoma. DMFS, IMRT, NPC, OS, PFS
28  2018 Neoadjuvant Chemotherapy with Fluorouracil plus Nedaplatin or Cisplatin for Locally Advanced Nasopharyngeal Carcinoma: a Retrospective Study. CCRT, DMFS, IMRT, NPC, OS, PFS, RRFS
29  2018 Proposal of a Pretreatment Nomogram for Predicting Local Recurrence after Intensity-Modulated Radiation Therapy in T4 Nasopharyngeal Carcinoma: A Retrospective Review of 415 Chinese Patients. C-index, IMRT, NPC
30  2018 Suggestions for surveillance and radiation strategy in nasopharyngeal carcinoma treated with IMRT: Based on hazard-rate and patterns of recurrence. IMRT, LRRFS, NPC
31  2018 Technical feasibility of endoscopic submucosal dissection for local failure after chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma. ESCC, ESD
32  2018 The detrimental effects of radiotherapy interruption on local control after concurrent chemoradiotherapy for advanced T-stage nasopharyngeal carcinoma: an observational, prospective analysis. IMRT, OS, ROC, RTI
33  2018 Treatment of hepatic metastases with computed tomography-guided interstitial brachytherapy. CT, HDR, OS, PFS
34  2018 Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study. CI, DMFS, HR, NATN, OS, TNAC
35  2017 Comparison of the efficacy between intensity-modulated radiotherapy and two-dimensional conventional radiotherapy in stage II nasopharyngeal carcinoma. DFS, DMFS, IMRT, NPC, OS, RRFS
36  2017 Gemcitabine/cisplatin induction chemotherapy before concurrent chemotherapy and intensity-modulated radiotherapy improves outcomes for locoregionally advanced nasopharyngeal carcinoma. CC, DMFS, GP, IC, IMRT, NPC, OS, PFS, RRFS
37  2017 Influence of Cervical Node Necrosis of Different Grades on the Prognosis of Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiotherapy. CNN, DFS, DMFS, IMRT, MRI, NPC, OS, RRFS
38  2017 Mammographic calcification can predict outcome in women with breast cancer treated with breast-conserving surgery. BCS, CI, DFS, OS, RR
39  2017 Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis. CSS, HRs, NLR, NPC, OS, PFS
40  2017 Prognostic Factors in Surgical Patients with Chordomas of the Cervical Spine: A Study of 52 Cases from a Single Institution. OS
41  2017 Prognostic value of masticatory muscle involvement in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy. DFS, DMFS, IMRT, LP, MM, MP, NPC, OS, UICC/AJCC
42  2017 Prognostic Value of Serum Lactate Dehydrogenase in Patients with Nasopharyngeal Carcinoma: a Meta-Analysis. CI, DFS, DMFS, HRs, NPC, OS, S-LDH
43  2017 Survival and Toxicities of IMRT Based on the RTOG Protocols in Patients with Nasopharyngeal Carcinoma from the Endemic Regions of China. DMFS, FFS, IMRT, NPC, OS, RRFS
44  2017 The feasibility of contralateral lower neck sparing intensity modulation radiated therapy for nasopharyngeal carcinoma patients with unilateral cervical lymph node involvement. DFS, DMFS, IMRT, NPC, NRFS, OS
45  2017 The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma. ADC, DMFS, DWI, NPC, OS
46  2017 Validation of the 8th edition of the UICC/AJCC staging system for nasopharyngeal carcinoma treated with intensity-modulated radiotherapy. DFS, DMFS, IMRT, NPC, OS, UICC/AJCC
47  2016 A multicentre randomised clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer. CC, CR, CRT, DFS, HT, OS
48  2016 A new staging system for nasopharyngeal carcinoma based on intensity-modulated radiation therapy: results of a prospective multicentric clinical study. DMFS, IMRT, MRI, NPC, OS
49  2016 Clinical Features and Prognostic Factors of Patients With Nerve Sheath Tumors in the Cervical Spine. CSNSTs, OS
50  2016 Clinical Features and Prognostic Factors of Pediatric Spine Tumors: A Single-Center Experience With 190 Cases. OS, PSTs
51  2016 Hypoxia-inducible proteins HIF1alpha and lactate dehydrogenase LDH5, key markers of anaerobic metabolism, relate with stem cell markers and poor post-radiotherapy outcome in bladder cancer. HIF-1alpha, LDH5
52  2016 Invasive micropapillary carcinoma of the breast had poor clinical characteristics but showed no difference in prognosis compared with invasive ductal carcinoma. DMFS, FFS, IDC, IMPC, OS
53  2016 Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5cm. CTP, DMFS, EQD2, HCC, OS, PFS, SBRT, TACE, TAE
54  2016 Primary tumor inflammation in gross tumor volume as a prognostic factor for nasopharyngeal carcinoma patients. DFS, DMFS, IMRT, NPC, OS, PTI
55  2016 Prognostic implications of dynamic serum lactate dehydrogenase assessments in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. DFS, DMFS, IMRT, LDH, NPC, OS
56  2016 Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy. DFS, DMFS, GTV-P, IMRT, NPC, OS, ROC
57  2016 Prognostic value of the distance between the primary tumor and brainstem in the patients with locally advanced nasopharyngeal carcinoma. AJCC, Dbs, DFS, DMFS, IMRT, NPC, OS, ROC
58  2016 Recommendations for Updating T and N Staging Systems for Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy. AJCC, DMFS, OS
59  2016 Should All Nasopharyngeal Carcinoma with Paranasal Sinus Invasion Be Staged as T3 in the Intensity-Modulated Radiotherapy Era? A Study of 1811 Cases. IMRT, NPC
60  2016 Time interval between surgery and start of adjuvant radiotherapy in patients with soft tissue sarcoma: A retrospective analysis of 1131 cases from the French Sarcoma Group. OS, RT, STS, TI
61  2016 Treatment of nasopharyngeal carcinoma using simultaneous modulated accelerated radiation therapy via helical tomotherapy: a phase II study. DMFS, LNRFS, NPC, NRFS, OS, SMART
62  2015 A retrospective study of the prognostic value of MRI-derived residual tumors at the end of intensity-modulated radiotherapy in 358 patients with locally-advanced nasopharyngeal carcinoma. DFS, IMRT, MRI, OS
63  2015 Aggressive surgical treatment with bony pelvic resection for locally recurrent rectal cancer. DFS, LRRC
64  2015 Clinical features and prognostic factors of patients with chordoma in the spine: a retrospective analysis of 153 patients in a single center. KPS, OS
65  2015 Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage I and II disease. DFS, DSS, MFS, NRFS, OS, PLR, RR
66  2015 Comparison of the treatment outcomes of intensity-modulated radiotherapy and two-dimensional conventional radiotherapy in nasopharyngeal carcinoma patients with parapharyngeal space extension. CS, DMFS, IMRT, NPC, OS, PPS
67  2015 Efficacy of concurrent chemoradiotherapy for patients with locally recurrent or advanced inoperable breast cancer. CI, CR, CRT, HR, OS, PR
68  2015 Impact of intensity-modulated radiotherapy on nasopharyngeal carcinoma: Validation of the 7th edition AJCC staging system. DMFS, DSS, HRs, IMRT, MRI, NPC, OS
69  2015 Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up. DMFS, IMRT, LRRFS, NPC, NRFS, OS, PFS
70  2015 Is maximum primary tumor diameter still a prognostic factor in patients with nasopharyngeal carcinoma treated using intensity-modulated radiotherapy? DMFS, FFS, IMRT, MPTD, MRI, NPC, OS, ROC
71  2015 Long-term outcomes and failure patterns of patients with nasopharyngeal carcinoma staged by magnetic resonance imaging in intensity-modulated radiotherapy era: The Zhejiang Cancer Hospital's experience. DM, IMRT, MRI, NPC, PTV
72  2015 Nasopharyngeal carcinoma patients with retropharyngeal lymph node metastases: a minimum axial diameter of 6 mm is a more accurate prognostic predictor than 5 mm. AJCC, DMFS, NPC, OS, RLNs
73  2015 Pretreatment Serum Lactate Dehydrogenase and N Classification Predict Long-Term Survival and Distant Metastasis in Patients With Nasopharyngeal Carcinoma Who Have A Positive Family History of Cancer. DFS, DMFS, FH, NPC, OS
74  2015 Prognostic value of classifying parapharyngeal extension in nasopharyngeal carcinoma based on magnetic resonance imaging. DMFS, MRI, NPC, OS
75  2015 Prognostic value of MRI-derived masticator space involvement in IMRT-treated nasopharyngeal carcinoma patients. DMFS, IMRT, ITF, LPM, MPM, MRI, MSI, NPC, OS, RRFS
76  2015 Radical trimodality therapy for patients with locally advanced bladder cancer: The British Columbia Cancer Agency experience. BCSS, OS, RTMT
77  2015 The effect of adjuvant chemotherapy on survival in patients with residual nasopharyngeal carcinoma after undergoing concurrent chemoradiotherapy. AC, CCRT, DMFS, FFS, NPC, OS
78  2015 The prognosis of nasopharyngeal carcinoma involving masticatory muscles: a retrospective analysis for revising T subclassifications. DMFS, MMs, MRI, NPC, OS
79  2014 A new T classification based on masticator space involvement in nasopharyngeal carcinoma: a study of 742 cases with magnetic resonance imaging. DFS, DMFS, IFI, MLPI, MRI, MSI, NPC, OS
80  2014 Clinical outcomes of local excision following preoperative chemoradiotherapy for locally advanced rectal cancer. DMFS, OS, RFS
81  2014 Clinical study of nasopharyngeal carcinoma treated by helical tomotherapy in China: 5-year outcomes. DMFS, HT, NPC, NRFS, OS
82  2014 Does MRI-detected cranial nerve involvement affect the prognosis of locally advanced nasopharyngeal carcinoma treated with intensity modulated radiotherapy? CNI, DMFS, IMRT, MRI, NPC, OS
83  2014 Impact of preoperative anemia on relapse and survival in breast cancer patients. DMFS, Hb, LNMFS, OS, RFS
84  2014 Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancer. DFS, DRFS
85  2014 MRI-detected skull-base invasion: prognostic value and therapeutic implication in intensity-modulated radiotherapy treatment for nasopharyngeal carcinoma. DFS, DMFS, IMRT, MRI, NPC, OS
86  2014 Primary tumor regression speed after radiotherapy and its prognostic significance in nasopharyngeal carcinoma: a retrospective study. CI, CRPT, DMFS, FFS, HR, NPC, OS, PRPT, PT, RT, SDPT
87  2014 Prognostic value of parapharyngeal extension in nasopharyngeal carcinoma treated with intensity modulated radiotherapy. DFS, DMFS, IMRT, MRI, NPC
88  2014 Salvage treatment for locally recurrent nasopharyngeal carcinoma (NPC). NPC
89  2014 Should women younger than 40 years of age with invasive breast cancer have a mastectomy? 15-year outcomes in a population-based cohort. BCSS, BCT, DRFS, LRRFS, MRM, OS
90  2014 Treatment outcomes and feasibility of partial neck irradiation for patients with nasopharyngeal carcinoma with only retropharyngeal lymph node metastasis after intensity-modulated radiotherapy. DFS, DMFS, NPC, RLNs, RRFS
91  2013 External-beam radiotherapy and/or HDR brachytherapy in postoperative endometrial cancer patients: clinical outcomes and toxicity rates. DFS, EBRT, OS, VBT
92  2013 High DLL4 expression in tumour-associated vessels predicts for favorable radiotherapy outcome in locally advanced squamous cell head-neck cancer (HNSCC). DLL4, VD
93  2013 Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) as a prognostic marker for local control in T1-2 N0 breast cancer treated with breast-conserving surgery and radiation therapy (BCS + RT). DFS, HER2, IFIT1, OS, TNBC
94  2013 Nasopharyngeal cancer: impact of skull base invasion on patients prognosis and its potential implications on TNM staging. DMFS, MRI, NPC, OS, QOL
95  2013 Prognostic significance of maximum primary tumor diameter in nasopharyngeal carcinoma. DMFS, FFS, MPTD, NPC, OS
96  2013 Prognostic value and differences of the sixth and seventh editions of the UICC/AJCC staging systems in nasopharyngeal carcinoma. OS
97  2013 Surgery quality and tumor status impact on survival and local control of resectable liposarcomas of extremities or the trunk wall. DFS, DSS, LPS
98  2013 The relative benefits of tamoxifen in older women with T1 early-stage breast cancer treated with breast-conserving surgery and radiation therapy. DMFS, OS, TAM
99  2012 A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases. DFS, OS, SBRT
100  2012 Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma? AJCC, DFS, DMFS, GTV-P, IMRT, NPC, OS, ROC